David A. Siegel Mirum Pharmaceuticals, Inc. Transaction History

Two Sigma Advisers, LP

$47 Billion
Q3 2025

A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Mirum Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Advisers, LP holds 276,400 shares of MIRM stock, worth $19.7 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares

276,400

Previous 171,400 61.26%

Holding current value

$19.7 Million

Previous $8.72 Million 132.31%

% of portfolio

0.04%

Previous 0.02%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$48.39 - $77.69 $5.08 Million - $8.16 Million	105,000 Added 61.26%	276,400 $20.3 Million
Q2 2025 Aug 14, 2025	SELL	$38.39 - $51.11 $1.35 Million - $1.8 Million	-35,200 Reduced 17.04%	171,400 $8.72 Million
Q1 2025 May 15, 2025	BUY	$41.32 - $53.16 $1.33 Million - $1.71 Million	32,200 Added 18.46%	206,600 $9.31 Million
Q4 2024 Feb 14, 2025	SELL	$37.85 - $46.65 $1.18 Million - $1.45 Million	-31,100 Reduced 15.13%	174,400 $7.21 Million
Q3 2024 Nov 14, 2024	BUY	$33.68 - $44.74 $862,208 - $1.15 Million	25,600 Added 14.23%	205,500 $8.01 Million

Q2 2024 Aug 14, 2024	SELL	$23.57 - $34.85 $403,047 - $595,935	-17,100 Reduced 8.68%	179,900 $6.15 Million
Q1 2024 May 15, 2024	SELL	$24.92 - $30.02 $3.47 Million - $4.18 Million	-139,300 Reduced 41.42%	197,000 $4.95 Million
Q4 2023 Feb 14, 2024	SELL	$27.14 - $34.93 $1.48 Million - $1.91 Million	-54,600 Reduced 13.97%	336,300 $9.93 Million
Q3 2023 Nov 14, 2023	BUY	$24.63 - $32.85 $8.09 Million - $10.8 Million	328,300 Added 524.44%	390,900 $12.4 Million
Q2 2023 Aug 14, 2023	BUY	$23.51 - $30.09 $759,373 - $971,907	32,300 Added 106.6%	62,600 $1.62 Million
Q1 2023 May 15, 2023	SELL	$19.19 - $24.1 $949,905 - $1.19 Million	-49,500 Reduced 62.03%	30,300 $727,000
Q4 2022 Feb 14, 2023	SELL	$17.59 - $23.83 $564,639 - $764,943	-32,100 Reduced 28.69%	79,800 $1.56 Million
Q3 2022 Nov 14, 2022	SELL	$19.98 - $29.44 $921,078 - $1.36 Million	-46,100 Reduced 29.18%	111,900 $2.35 Million
Q2 2022 Aug 15, 2022	SELL	$18.42 - $27.5 $843,636 - $1.26 Million	-45,800 Reduced 22.47%	158,000 $3.08 Million
Q1 2022 May 16, 2022	BUY	$15.5 - $23.93 $558,899 - $862,867	36,058 Added 21.5%	203,800 $4.49 Million
Q4 2021 Feb 14, 2022	BUY	$13.05 - $19.35 $968,858 - $1.44 Million	74,242 Added 79.4%	167,742 $2.68 Million
Q3 2021 Nov 15, 2021	BUY	$13.95 - $20.18 $163,215 - $236,106	11,700 Added 14.3%	93,500 $1.86 Million
Q2 2021 Aug 16, 2021	BUY	$15.84 - $20.6 $199,584 - $259,560	12,600 Added 18.21%	81,800 $1.41 Million
Q1 2021 May 17, 2021	BUY	$16.29 - $21.92 $750,969 - $1.01 Million	46,100 Added 199.57%	69,200 $1.37 Million
Q4 2020 Feb 16, 2021	BUY	$15.75 - $25.45 $363,825 - $587,895	23,100 New	23,100 $403,000

Others Institutions Holding MIRM

# of Institutions

290

Shares Held

57.5M

Call Options Held

86.1K

Put Options Held

105K

View Full List

About Mirum Pharmaceuticals, Inc.

Ticker MIRM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,751,700
Market Cap $2.63B
Description
Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. The company's lead product candidate is LIVMARLI, an investigational oral drug for the treatment of progressive familial intrahepatic cholestasis disease, as well as for the trea...

More about MIRM

Track David A. Siegel's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Account